Tendon injuries are common in both veterinary and human clinical patients and result in
morbidity, pain, and lost athletic performance. Consequently, utilizing naturally occurring …

The purpose of this manuscript, which is part of the Currents in One Health series, is to take
a comparative approach to stem cell treatment for tendon injury and consider how the horse …

Tendon injury in the horse carries a high morbidity and monetary burden. Despite
appropriate therapy, reinjury is estimated to occur in 50–65% of cases. Although …

Tendon injuries are a common age-related degenerative condition where current treatment
strategies fail to restore functionality and normal quality of life. This disease also occurs …

OBJECTIVE Mesenchymal stromal (stem) cells (MSCs) have been studied to treat many
common orthopedic injuries in horses. However, there is limited information available on …

Tendon injuries represent a challenge in orthopedics due to limited regeneration and
frequentre-injuries. Treatment with multipotent mesenchymal stromal cells (MSC) is a …

Stem cells have evoked considerable excitement in the animal-owning public because of
the promise that stem cell technology could deliver tissue regeneration for injuries for which …

Optimal management of tendon overuse injuries in equine and human athletes should avoid
the formation of excessive scar tissue, regenerate normal tendon matrix, and reduce re …

The goal in the therapeutic use of mesenchymal stem cells (MSCs) in musculoskeletal
disease is to harness the regenerative nature of these cells focussing on their potential to …

Overuse tendon injuries are a major cause of musculoskeletal morbidity in both human and
equine athletes, due to the cumulative degenerative damage. These injuries present …